{"id":1805,"date":"2017-02-07T16:49:53","date_gmt":"2017-02-07T21:49:53","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1805"},"modified":"2017-02-07T16:49:53","modified_gmt":"2017-02-07T21:49:53","slug":"02-07-2017-secondary-announcement-p-m","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/02-07-2017-secondary-announcement-p-m\/","title":{"rendered":"02.07.2017 Secondary Announcement-p.m."},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n<p>Company:\tCoherus Biosciences<br \/>\nSymbol:\tCHRS<br \/>\nPrice:\t\tLast trade $26.65<br \/>\nDescription:\tRe-offer range $24.00-$25.00<br \/>\nTrade Date:\t2\/8<br \/>\nShares:\t\t4.7 million<br \/>\nUnderwriter(s)J.P. Morgan, Citigroup, Cowen &#038; Co., BMO Capital Markets<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tAMC Entertainment<br \/>\nSymbol:\tAMC<br \/>\nPrice:\t\tLast trade $32.47<br \/>\nDescription:\tRe-offer range $31.50-$32.00<br \/>\nTrade Date:\t2\/8<br \/>\nShares:\t\t15.4 million<br \/>\nUnderwriter(s)Citigroup, BofA Merrill Lynch<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tParsley Energy<br \/>\nSymbol:\tPE<br \/>\nPrice:\t\tLast trade $33.33<br \/>\nDescription:\tRe-offer $30.75-$32.00<br \/>\nTrade Date:\t2\/8<br \/>\nShares:\t\t36 million<br \/>\nUnderwriter(s)Morgan Stanley, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Scotiabank, J.P. Morgan<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tGalena Biopharma<br \/>\nSymbol:\tGALE<br \/>\nPrice:\t\tLast trade $1.40<br \/>\nDescription:\tRe-offer range is not available<br \/>\nTrade Date:\t2\/8<br \/>\nShares:\t\t10.7 million<br \/>\nUnderwriter(s)Canaccord Genuity<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tGolar LNG Partners<br \/>\nSymbol:\tGMLP<br \/>\nPrice:\t\tLast trade $24.54<br \/>\nDescription:\tRe-offer range $23.00-$23.50<br \/>\nTrade Date:\t2\/8<br \/>\nShares:\t\t4.5 million<br \/>\nUnderwriter(s)Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Coherus Biosciences Symbol: CHRS Price: Last trade $26.65 Description: Re-offer range $24.00-$25.00 Trade Date: 2\/8 Shares: 4.7 million Underwriter(s)J.P. Morgan, Citigroup,[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[1059,274,1060,1061,629],"class_list":["post-1805","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-amc","tag-chrs","tag-gale","tag-gmlp","tag-pe"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1805"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1805\/revisions"}],"predecessor-version":[{"id":1806,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1805\/revisions\/1806"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}